Halak Brian K Insider Trades

Insider Trading History

Track insider trading activity for Halak Brian K. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $33.2k 6,000 shares
Last Trade
Jan 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.3k 6,000 shares
$2.72
$5.54
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $33.2k 6,000 shares
Last Trade
Nov 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 6,000 shares
$4.05
$5.54
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $1.81k 327 shares
Last Trade
Sep 17, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.04k 215 shares
$4.86
$5.54
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $18.5k 3,333 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.3k 3,333 shares
$6.70
$5.54
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $277k 50,000 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$690k 50,000 shares
$13.80
$5.54
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $98.9M 2,588,024 shares
Last Trade
Nov 06, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38M 104,328 shares
$13.19
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $103M 2,690,091 shares
Last Trade
Nov 05, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$518k 39,901 shares
$12.98
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $104M 2,729,697 shares
Last Trade
Nov 02, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.57M 190,771 shares
$13.47
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
10% owner
Holding Value $112M 2,919,056 shares
Last Trade
Nov 01, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.54M 190,275 shares
$13.37
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
10% owner
Holding Value $119M 3,107,923 shares
Last Trade
Oct 31, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76M 129,629 shares
$13.60
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
10% owner
Holding Value $127M 3,327,511 shares
Last Trade
Oct 30, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.41M 245,096 shares
$13.92
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $956k 25,000 shares
Last Trade
Jun 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$327k 25,000 shares
$13.08
$38.22
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $222k 40,000 shares
Last Trade
Jun 19, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$516k 40,000 shares
$12.90
$5.54
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $133M 3,479,875 shares
Last Trade
Jun 07, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$148k 10,271 shares
$14.45
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $0 0 shares
Last Trade
Jun 07, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.17k 156 shares
$13.94
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $133M 3,490,070 shares
Last Trade
Jun 07, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 21,197 shares
$13.94
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
10% owner
Holding Value $956k 25,000 shares
Last Trade
Jul 18, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.5k 25,000 shares
$3.42
$38.22
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $222k 40,000 shares
Last Trade
Jun 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$822k 40,000 shares
$20.55
$5.54
Alimera Sciences
Alimera Sciences ALIM
Director
Holding Value $111k 20,000 shares
Last Trade
Jun 23, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$447k 20,000 shares
$22.35
$5.54
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $573k 15,000 shares
Last Trade
Jun 14, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.9k 15,000 shares
$3.26
$38.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up